Chemoprevention of prostate cancer with finasteride
- PMID: 16634712
- DOI: 10.1517/14656566.7.7.899
Chemoprevention of prostate cancer with finasteride
Abstract
Prostate cancer is a significant cause of disease and death, making it an attractive target for chemoprevention. The association between lifetime exposure to dihydrotestosterone and risk of developing prostate cancer suggests that chemoprevention is possible with 5alpha-reductase inhibition. The recently completed Prostate Cancer Prevention Trial indicates that chemoprevention is possible with the 5alpha-reductase inhibitor finasteride. Development of a cost-effective chemoprevention strategy for prostate cancer is evolving, and is expected to have significant positive economic and public health benefits.
Similar articles
-
Chemoprevention using dutasteride: the REDUCE trial.Curr Opin Urol. 2005 Jan;15(1):29-32. doi: 10.1097/00042307-200501000-00007. Curr Opin Urol. 2005. PMID: 15586026 Review.
-
Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.Prostate. 1997 Nov 1;33(3):217-21. doi: 10.1002/(sici)1097-0045(19971101)33:3<217::aid-pros11>3.0.co;2-n. Prostate. 1997. PMID: 9365551 Clinical Trial.
-
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase.BJU Int. 2009 Nov;104(9):1191-7. doi: 10.1111/j.1464-410X.2009.08743.x. Epub 2009 Jul 14. BJU Int. 2009. PMID: 19624596 Review.
-
Prostate cancer prevention trial yields positive results, but with a few cautions.J Natl Cancer Inst. 2003 Jul 16;95(14):1030-1. doi: 10.1093/jnci/95.14.1030. J Natl Cancer Inst. 2003. PMID: 12865442 No abstract available.
-
Chemoprevention of prostate cancer.Urol Clin North Am. 2010 Feb;37(1):11-21, Table of Contents. doi: 10.1016/j.ucl.2009.11.003. Urol Clin North Am. 2010. PMID: 20152515 Review.
Cited by
-
The evolving biology and treatment of prostate cancer.J Clin Invest. 2007 Sep;117(9):2351-61. doi: 10.1172/JCI31791. J Clin Invest. 2007. PMID: 17786228 Free PMC article.
-
Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer.Int J Mol Sci. 2023 Jan 9;24(2):1305. doi: 10.3390/ijms24021305. Int J Mol Sci. 2023. PMID: 36674820 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical